Status:
TERMINATED
The Use of Light Therapy for Managing Sleep Disturbances in Patients With Advanced Cancer
Lead Sponsor:
M.D. Anderson Cancer Center
Conditions:
Advanced Cancers
Eligibility:
All Genders
18+ years
Phase:
PHASE2
PHASE3
Brief Summary
The goal of this research study is to learn if a type of light therapy can be used to help patients with advanced cancer who are having difficulty sleeping to sleep better.
Detailed Description
Study Groups: If you are found to be eligible to take part in this study, you will be randomly assigned (as in the flip of a coin) to one of two groups: * Group 1 will receive one type of light ther...
Eligibility Criteria
Inclusion
- Advanced cancer patients seen in Supportive Care outpatient clinic at M.D. Anderson Cancer Center, with average sleep disturbance \>=4 out of 10 for at least one week
- Age 18 or greater
- Karnofsky performance status score of \>=40 at time of inclusion into study
- Agrees to return to MD Anderson Cancer Center (MDACC) for follow-up visits
- English speaking
Exclusion
- Persons with congenital blindness and self-reported acquired blindness (independent of the cause) with no light perception
- Patients with a history of retinal disease
- Patients with a current diagnosis of major depression disorder or generalized anxiety disorder
- Patients who have received light therapy in the past either as part of treatment for other disorders or as a study subject
- Patients currently on amiodarone, thiazide diuretics or epidermal growth factor receptor (EGFR) inhibitors (erlotinib, gefitinib, cetuximab, panitumumab)
- Patients who are currently receiving ultraviolet A light/ultraviolet B light (UVA/UVB) therapy or tanning sessions at salons
- Patients with a diagnosis of obstructive sleep apnea or narcolepsy
- Patients with \>2 hours of direct exposure to outdoor natural light per day (light exposure diary -- screening).
Key Trial Info
Start Date :
June 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2016
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT01193530
Start Date
June 1 2011
End Date
March 1 2016
Last Update
March 26 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Texas MD Anderson Cancer Center
Houston, Texas, United States, 77030